PR98289

SINGAPORE, Oct. 14, 2022 /PRNewswire=KYODO JBN/ --

On October 11, Yili Group was invited to deliver a keynote speech at the Growth

Asia Summit in Singapore, where the dairy producer shared insights on the role

dairy can play in healthy ageing in APAC.

Dr. Philip Wescombe, R&D Manager at Yili Group, explained that the key to

Yili's approach to healthy aging is understanding the important role of good

nutrition at all ages. As a consumer-centric company driven by the motto of "no

innovation, no future", Yili is committed to developing products that cater to

the needs of all consumers at all life stages and scenarios, to ensure that no

one is left behind in enjoying a healthy life.

All-round nutritional support for consumers at all life stages

To understand and meet the diverse nutritional requirements of its consumers,

Yili has carried out many studies on the needs of different age groups.

This year, Yili supported the China Population Welfare Foundation to publish a

comprehensive report that provides professional dietary guidance for various

groups.

In addition, Yili, in collaboration with Peking University, conducted in-depth

analysis of the original data collected from the four-year "Survey on Dietary

Nutrition and the Health Status of Adults Across Eight Cities in China" and has

used this information to develop products targeted at alleviating or preventing

metabolic disease.

To extend the nutritional benefits of dairy products to more consumers, Yili's

R&D team launched China's first SHUHUA Lactose-Free Milk to cater to those who

are lactose intolerant. Meanwhile, with rich dietary fiber content, Yili's

XinHuo milk powder supplements the nutritional needs of adult consumers by

balancing the body's blood glucose levels and supporting the regulation of

bodily functions.

Research-driven innovation

Dr. Wescombe also shared Yili's innovative practices for developing probiotic

products in his keynote speech.

Drawing from the resources of its global innovation network, Yili has developed

four platforms covering the entire value chain. These four platforms involve

the establishment of a resource bank of probiotic strains, the development and

clinical evaluation of probiotic functions, the application of probiotic

strains and fermentation technology, and the processing of strains and quality

control, respectively.

BL-99, which had been isolated from the intestines of healthy Chinese infants,

is the first probiotic bacterial strain independently developed by Yili

following 10 years of scientific research. The strain has proved to be

effective in promoting digestion, regulating intestinal flora, assisting bone

health, and enhancing immunity, and has been added to Yixiao yogurt, Yili

Cheese Bar for Kids, and NOC xujinhuan ice cream.

This June, Yili introduced a BL-99 probiotics product customized for people

over 45. Combined with GABA and dual-prebiotics, the product is designed to

help maintain the balance of intestinal flora.

To date, Yili has established 15 R&D and innovation centers worldwide and

actively engages to build a global health ecosystem. Adhering to its vision of

"World Integrally Sharing Health", Yili is dedicated to developing products to

provide better nutritional outcomes for consumers around the world.

SOURCE  Yili Group

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=431533

   Caption: Dr. Philip Wescombe explained dairy’s crucial role in boosting healthy ageing